Found: 14
Select item for more details and to access through your institution.
Intrapulmonary Autoantibodies to HSP72 Are Associated with Improved Outcomes in IPF.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Galectin-3 inhibitor GB0139 protects against acute lung injury by inhibiting neutrophil recruitment and activation.
- Published in:
- Frontiers in Pharmacology, 2022, v. 10, p. 1, doi. 10.3389/fphar.2022.949264
- By:
- Publication type:
- Article
Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo.
- Published in:
- Nature Medicine, 1999, v. 5, n. 6, p. 662, doi. 10.1038/9511
- By:
- Publication type:
- Article
Selective Myeloid Depletion of Galectin-3 Offers Protection Against Acute and Chronic Lung Injury.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.715986
- By:
- Publication type:
- Article
Proteinase Activated Receptor 1 Mediated Fibrosis in a Mouse Model of Liver Injury: A Role for Bone Marrow Derived Macrophages.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0086241
- By:
- Publication type:
- Article
An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE).
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 207, n. 2, p. 138, doi. 10.1164/rccm.202203-0477OC
- By:
- Publication type:
- Article
Resistance to anti-PD-1/anti-PDL1: galectin-3 inhibition with GB1211 reverses galectin-3- induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1250559
- By:
- Publication type:
- Article
Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Regulation of Transforming Growth Factor-β1--driven Lung Fibrosis by Galectin-3.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2012, v. 185, n. 5, p. 537, doi. 10.1164/rccm.201106-0965OC
- By:
- Publication type:
- Article
Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Ly6C<sup>hi</sup> Monocytes Direct Alternatively Activated Profibrotic Macrophage Regulation of Lung Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2011, v. 184, n. 5, p. 569, doi. 10.1164/rccm.201010-1719OC
- By:
- Publication type:
- Article
Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 3, p. 267, doi. 10.1007/s00280-023-04513-y
- By:
- Publication type:
- Article
The molecular and cellular biology of lung cancer: identifying novel therapeutic strategies.
- Published in:
- British Medical Bulletin, 2010, v. 95, n. 1, p. 47, doi. 10.1093/bmb/ldq023
- By:
- Publication type:
- Article
Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.
- Published in:
- Glycobiology, 2013, v. 23, n. 6, p. 654, doi. 10.1093/glycob/cwt006
- By:
- Publication type:
- Article